Fevertree Drinks plc
( "Fever-Tree" or the "Company")
Director/PDMR Shareholding
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 14 September 2020, pursuant to the Company's 2016 and 2017 Long Term Incentive Plan, Tim Warrillow, Chief Executive Officer, and Andrew Branchflower, Chief Financial Officer, exercised options over 171,155 and 78,821 ordinary shares of 0.25 pence each ("Ordinary Shares") respectively. The Company was notified that, on 14 September 2020, Tim Warrillow and Andrew Branchflower subsequently sold 171,155 and 78,821 Ordinary Shares respectively at a volume weighted average price of 2,018.8 pence per Ordinary Share.
Following this transaction, there is no change to their respective shareholdings in the Company. Tim Warrillow remains interested in 5,460,172 Ordinary Shares, representing approximately 4.7% of the Company's issued share capital. Andrew Branchflower remains interested in 141,488 Ordinary Shares, representing approximately 0.1% of the Company's issued share capital.
The exercise of these options has been satisfied by the Company's existing block listing arrangements.
For further information:
Investor queries
Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024
Nominated Advisor and Joint Broker - Numis Securities
Garry Levin I Matt Lewis I Hugo Rubinstein I +44 (0)20 7260 1000
Joint Broker - Investec Bank plc
David Flin I Alex Wright I +44 (0)20 7597 5970
Financial PR advisers - Finsbury
Faeth Birch +44 (0)7768 943 171; Chris Ryall +44 (0)7342 713 748; Amanda Healy +44 (0)7795 051 635
Notes to Editors:
Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 75 countries worldwide.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||
a) |
Name |
1. Tim Warrillow 2. Andrew Branchflower |
||||||||||||
2 |
Reason for the notification |
|||||||||||||
a) |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer |
||||||||||||
b) |
Initial notification/Amendment |
1. Initial notification 2. Initial notification |
||||||||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||
a) |
Name |
|
||||||||||||
b) |
LEI |
2138007AJRLHRVQZLD07
|
||||||||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
|
||||||||||||
b) |
Nature of the transaction |
Exercise of options over Ordinary Shares |
||||||||||||
c) |
Price(s) and volume(s) |
|
||||||||||||
d) |
Aggregated information
|
|
||||||||||||
e) |
Date of the transaction |
14 September 2020 |
||||||||||||
f) |
Place of the transaction |
London Stock Exchange |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||
a) |
Name |
1. Tim Warrillow 2. Andrew Branchflower |
||||||||||||
2 |
Reason for the notification |
|||||||||||||
a) |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer |
||||||||||||
b) |
Initial notification/Amendment |
1. Initial notification 2. Initial notification |
||||||||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||
a) |
Name |
|
||||||||||||
b) |
LEI |
2138007AJRLHRVQZLD07
|
||||||||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
|
||||||||||||
b) |
Nature of the transaction |
Sale of Ordinary Shares |
||||||||||||
c) |
Price(s) and volume(s) |
|
||||||||||||
d) |
Aggregated information
|
1. n/a single trade 2. n/a single trade
|
||||||||||||
e) |
Date of the transaction |
14 September 2020 |
||||||||||||
f) |
Place of the transaction |
London Stock Exchange |